missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. Cyclin E1, p Thr77 Antibody (SR1828), Novus Biologicals™
  7. 18663675

Cyclin E1, p Thr77 Antibody (SR1828), Novus Biologicals™

Rabbit Monoclonal Antibody

Brand:  Novus Biologicals NBP3-21555-50ul

 View more versions of this product

Product Code. 18663675

  • 338.00 EUR / 50µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Cyclin E1 Monoclonal antibody specifically detects Cyclin E1 in Human samples. It is validated for Western Blot, Immunohistochemistry, Immunofluorescence
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Cyclin E1
Monoclonal
Unconjugated
PBS, pH 7.4, 150mM NaCl, 50% glycerol.
Rabbit
Affinity purified
RUO
Primary
Human
Purified
Western Blot, Immunohistochemistry, Immunofluorescence
SR1828
Western Blot 1:1000-1:2000, Immunohistochemistry 1:50-1:200, Immunocytochemistry/Immunofluorescence 1:50-1:200
CCNEcyclin Es, cyclin E1, cyclin Et, G1/S-specific cyclin-E1
A synthesized peptide derived from human phospho-Cyclin E1 [Thr77] (Uniprot #: P24864)
50 μg
Cancer, Cell Cycle and Replication, Cellular Markers, Ovarian Carcinoma Cell Markers, Phospho Specific
898
Store at -20 degrees C. Avoid freeze/thaw cycles.
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.